ANNUAL REPORT OF PURE BIOLOGICS S.A. FOR THE FINANCIAL YEAR 2021 – BRIEF SUMMARY
| SELECTED FINANCIAL DATA | in thousands PLN | in thousands PLN | in thousands EUR | in thousands EUR | |
| 2021 | 2020 | 2021 | 2020 | ||
| SELECTED ITEMS OF THE PROFIT AND LOSS STATEMENT | |||||
| I. Operating revenues | 18 033 | 16 659 |
3 939
|
3 723
|
|
| II. Total operating expenses | 28 492 |
28 315
|
6 224
|
6 329
|
|
| III. Operating profit (loss) |
-10 482
|
-11 554
|
-2 290
|
-2 582
|
|
| IV. Profit (loss) before tax |
-11 765
|
-11 756 |
-2 570
|
-2 627 | |
| V. Net profit (loss) |
-11 765
|
-11 756 |
-2 570
|
-2 627
|
|
| SELECTED ITEMS OF THE CASH FLOW | |||||
| VI. Net cash flows from operating activities | -24 035 |
-1 353
|
-5 251 | -302 | |
| VII. Net cash flows from investment activities | -28 478 |
-561
|
-6 221 | -125 | |
| VIII. Net cash flows from financial activities |
49 735
|
-3 051
|
10 865
|
-682 | |
| IX. Total net cash flows | -2 778 | -4 965 | -607 | -1 110 | |
| SELECTED ITEMS OF THE BALANCE SHEET | |||||
| X. Total assets/liabilities |
47 190
|
18 942 |
10 260
|
4 105
|
|
| XI. Fixed assets |
4 175
|
5 904 | 908 | 1 279 | |
| XII. Current assets |
43 015
|
13 038 | 9 352 |
2 825
|
|
| XIII. Equity |
39 486
|
-2 887
|
8 585 |
-626
|
|
| XIV. Liabilities and provisions for liabilities | 7 704 | 21 829 | 1 675 | 4 730 | |
| XV. Long-term liabilities |
2 155
|
3 828
|
468
|
830
|
|
| XVI. Short-term liabilities |
5 549
|
18 000
|
1 206
|
3 901 | |
| XVII. Average weighted number of ordinary shares |
2 221 123
|
1 654 000 | 2 221 123 | 1 654 000 | |
| XVIII. Profit (loss) per ordinary share (in PLN/EUR) |
-5,30
|
-7,11
|
-1,16 | -1,59 | |
| XIX. Number of shares at the end of the period | 2 254 000 |
1 654 000
|
2 254 000
|
1 654 000 | |
| XX. Book value per share (in PLN/EUR) | 17,78 | -1,75 |
3,87
|
-0,38
|
|
|
|
|||||
| The selected financial figures presented in the report have been converted into euro as follows: | |||||
| 1] Items relating to the statement of profit or loss and other comprehensive income, the cash flow statement and the statement of changes in equity were converted at an exchange rate representing the arithmetic mean of the exchange rates published by the National Bank of Poland on the last day of each month: | |||||
| – period from 01/01/2021 to 31/12/2021: PLN 4,5775 | |||||
| – period from 01/01/2020 to 31/12/2020: PLN 4,4742 | |||||
| Selected items of the profit and loss statement (I-V) and cash flow statement (VI-IX) presented in thousand PLN and thousand EUR for the financial year ended 31.12.2021 and 31.12.2020. | |||||
| 2] The balance sheet items were converted according to the average exchange rate announced by the National Bank of Poland, in force on the balance sheet date; this exchange rate amounted to: | |||||
| – As at 31/12/2021: PLN 4,5994 | |||||
| – As at 31/12/2020: PLN 4,6148 | |||||
| Selected items of the balance sheet (X-XX) presented in thousand PLN and thousand EUR as at 31.12.2021 and 31.12.2020. | |||||